Note K - Segment and Geographic Data

12 Months Ended

Dec. 31, 2024

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

NOTE K — SEGMENT AND GEOGRAPHIC DATA

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Chief  Executive Officer (the “CODM”). The Company conducts its business through two reportable segments: Dental and Medical. These segments offer different products and services to different customer base. The CODM assesses the financial performance of the segment and decides how to allocate resources based on Product sales, net, and Operating income (loss). The Company provides general corporate services to its segments; however, these services are not considered when making operating decisions and assessing segment performance. These services are reported under “Corporate Services” below and these include costs associated with executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities and public company compliance.

The following tables present information about our reportable and operating segments:

	2024
	Dental		Medical			Corporate			Total
Product sales, net	$	8,527,108	$	102,820		$	-		$	8,629,928
Cost of products sold		2,186,142		9,198			-			2,195,340
Gross Margin		6,340,966		93,622			-			6,434,588
Salaries & employee benefits		1,559,933		828,269			1,353,193			3,741,395
Stock-based compensation expense		-		2,078			1,343,044			1,345,122
Royalty expense		436,828		5,231			-			442,059
Marketing		439,830		89,539			31,526			560,895
Rent & occupancy costs		48,973		30,608			74,847			154,428
Consultants and professional services fees		252,136		818,052			2,284,403			3,354,591
Insurance		203,648		189,343			178,185			571,176
Warehousing expense		448,190		34,058			14,589			496,837
Regulatory expense		24,614		16,359			441,892			482,865
Travel expense		98,334		95,348			65,773			259,455
Research and development expense		835,851		22,916			-			858,767
Depreciation and amortization expense		-		-			37,448			37,448
Other segment items		416,587		19,571			450,349			886,507
Total operating expenses		4,764,924		2,151,372			6,275,249			13,191,545
Operating income (loss)		1,576,042		(2,057,750	)		(6,275,249	)		(6,756,957	)

	2023
	Dental		Medical			Corporate			Total
Product sales, net	$	9,761,444	$	66,000		$	-		$	9,827,444
Cost of products sold		2,731,426		303,406			-			3,034,832
Gross Margin		7,030,018		(237,406	)		-			6,792,612
Salaries & employee benefits		1,790,678		1,161,886			1,320,900			4,273,464
Stock-based compensation expense		15,723		7,158			1,444,545			1,467,426
Royalty expense		482,034		3,300			-			485,334
Marketing		505,428		145,974			103,768			755,170
Rent & occupancy costs		65,793		61,093			29,763			156,649
Consultants and professional services fees		169,366		1,199,221			1,741,528			3,110,115
Insurance		287,253		266,735			129,948			683,936
Warehousing expense		470,079		52,107			14,055			536,241
Regulatory expense		68,338		33,286			321,244			422,868
Travel expense		127,787		119,976			58,263			306,026
Research and development expense		614,952		86,426			-			701,378
Depreciation and amortization expense		4,243		2,787			54,882			61,912
Other segment items		347,740		330,816			260,011			938,567
Total operating expenses		4,949,414		3,470,765			5,478,907			13,899,086
Operating income (loss)		2,080,604		(3,708,171	)		(5,478,907	)		(7,106,474	)

December 31,2024
	Dental		Medical		Corporate		Total
Total Assets	$	5,359,734	$	444,513	$	3,992,825	$	9,797,072
		5,359,734		444,513		3,992,825		9,797,072
December 31,2023
	Dental		Medical		Corporate		Total
Total Assets	$	4,866,786	$	345,194	$	6,159,532	$	11,371,512
		4,866,786		345,194		6,159,532		11,371,512

The following table presents information about our operations by geographic area As of December 31, 2024 and 2023. Net sales by geographic area are based on the respective locations of our subsidiaries.

	Year Ended December 31, 2024						Year Ended December 31, 2023
Domestic: US	Dental		Medical		Grand Total		Dental		Medical		Grand Total
Instruments	$	806,885	$	4,000	$	810,885	$	1,002,697	$	1,000	$	1,003,697
Handpieces		4,284,952		55,900		4,340,852		4,270,898		12,000		4,282,898
Accessories		49,112		-		49,112		75,285				75,285
Grand Total	$	5,140,949	$	59,900	$	5,200,849	$	5,348,880	$	13,000	$	5,361,880
International: Rest of World
Instruments	$	868,169	$	39,000	$	907,169	$	1,251,354	$	25,000	$	1,276,354
Handpieces		2,476,988		3,920		2,480,908		2,845,734		28,000		2,873,734
Accessories		41,002				41,002		45,476				45,476
Grand Total	$	3,386,159	$	42,920	$	3,429,079	$	4,142,564	$	53,000	$	4,195,564
International: China
Instruments	$	-	$	-	$	-	$	270,000	$	-	$	270,000
Handpieces		-		-		-		-		-		-
Accessories		-		-		-		-		-		-
Grand Total	$	-	$	-	$	-	$	270,000	$	-	$	270,000
Total Product Sales	$	8,527,108	$	102,820	$	8,629,928	$	9,761,444	$	66,000	$	9,827,444